- About Us
- Advertise
- Contact Us
- Editorial Info
- Editorial Advisory Board
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2024 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
At DCAT With Piramal Pharma Solutions
Published on:
Piramal Pharma Solutions
Sponsored
Peter DeYoung, CEO, Piramal Pharma Solutions, talks about recent company achievements and key offerings, as well as current industry trends.
At a recent Drug, Chemical & Associated Technologies (DCAT) conference, Pharmaceutical Technology spoke with Peter DeYoung, CEO, Piramal Pharma Solutions, to learn more about the company's offerings. Watch to learn more about:
- Piramal's key service offerings and integrated solutions in the areas of oncology and ADCs.
- The current operating environment for CDMOs and industry trends.
- Piramal's strategy to expand its territorial footprint in the US beyond its existing facilities.